News posts – English language
Probe launched after tête-à-tête with French counterpart ANSM, whose ‘red box’ warning will be slapped on all finasteride 1 mg packaging next month March 5, 2023 Dear Friends: The British are coming—hopefully with a PFS-awareness program on par with that of the French. Dr. White does right According to a February 16 memo from Amelia […]
Stricken US college student corroborates red flag raised to 29,000 pharmacists Feb. 27, 2023 Dear Friends: Spraying finasteride on your scalp instead of ingesting it is no guarantee you won’t develop post-finasteride syndrome (PFS). So cautions Germany’s oldest and most widely read pharmaceutical journal. So, too, an American college senior who says his academic, social […]
Dec. 4, 2022 Dear Friends: French PFS awareness is going high-tech. ANSM, the Gallic nation’s drug-regulatory authority (DRA), last week unveiled plans to add a so-called “red-box” warning—that includes a QR code—on all finasteride 1 mg products in 2023. Intended to “reinforce information on adverse effects” of Propecia and generics, the warning reads: This medication […]
Reporter calls disclosure by nation’s drug-regulatory agency ‘shocking and unbelievable’ Nov. 2, 2022 Dear Friends: Anti-finasteride sentiment continues to run rife on Teutonic TV. Dürfen Die Das? (Can They Do That?), a newsmagazine show on the German public-broadcasting network NDR, last week debuted a 17-minute film titled Finasteride: Why Is This Hair-loss Drug Still on […]
Study marks first-ever demonstration of a successful PFS therapy in an animal model Oct. 29, 2022 Dear Friends: The neurosteroid allopregnanolone (ALLO) has proved effective in counteracting some of the finasteride-induced alterations in gut microbiota, according to new research at the University of Milano (UniMi). Titled Gut Inflammation Induced by Finasteride Withdrawal: Therapeutic Effect of […]
Israeli pharmacovigilance expert, meanwhile, calls for ‘revolution’ in ADR reporting after local family of PFS suicide case files suit against Merck Sept. 26, 2022 Dear Friends: If you’ve ever Googled “post-finasteride syndrome,” chances are you’ve earned a place in the annals of medicine. Researchers at the University of Southern California’s Keck School of Medicine (KSM) […]
But Patient Product Information not revised to include the potentially lethal adverse events Aug. 29, 2022 Dear Friends: Organon & Co., the Merck & Co. spinoff that now owns Propecia (finasteride 1 mg), has added a new adverse drug reaction (ADR) to the hair-loss remedy’s label: suicidality. Earlier this month, Organon updated the Adverse Reactions […]
Steve Kenney (1972-2014) was a beloved detective protecting the people of DeKalb County, GA Aug. 13, 2022 Dear Friends: In Mohit Khera’s groundbreaking PFS research, published in June 2020, the Director for Andrology Research at Baylor College of Medicine wrote, “Two patients (8%) in the 5ARI arm committed suicide during or after the study period.” […]
Aug. 4, 2022 Dear Friends: This month marks a full decade that we’ve been in the business of facilitating PFS research, generating awareness of the condition, providing support to patients suffering from the condition, and lobbying for stricter regulation so that fewer unsuspecting men develop the condition. Now, if at any time between August 2012 […]
‘How-to’ video encourages reporting of finasteride ADRs to Ministry of Health July 13, 2022 Dear Friends: France’s National Agency for the Safety of Medicines and Health Products (ANSM) last week published a dossier of educational materials on the growing number of adverse drug reactions (ADRs) to finasteride 1 mg, as experienced by men currently suffering […]